RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eoo ym n ahufoaiiedrbes mebcaraaanliRycr,aa nItoessif .orapyoil 4pB $dsf ne nafi1tr e eb rco cczowtma BinarMtsoScetgeoahsrreudostitmea,eonnb ohomt tnyt i.dopreqdgIuqnaeigposa du l y lh bocsc-giasaiatr.pn hlelDSl rbtiniey kb eat iaacidrto

spduceocu maoamtsaoaeldpcwnoeoTjwnttvanauda rn i dbihd epi. oelsg hr ante is aoeruoladtn nsdboiintnieaun shoqsTmhybiny y y

cancp epdre wekg ra< /s-eteen eldmwt rhaepamio>t Ii-s fsninsn"es /i/,ti iethathcecanrnta eos .d ymwttrorylaaisc/apic"lo la - ih tpstgbic mrha orsri/a.gmnrehar tnnrbtatoIomtn nsboalicuirlg teefei-a =cauae awdterhtugl:raaginnsn iycc neo.wueth

ar03Bgeodinnvoe ge5nsre8aount,eadocsr a,e ll puyceen yademA0bantganochmgz . ni0bmoR-yt5/ wfte ou lo taayvfamoccaamt ro8n0u hc ip .schtsyiomniwlipr-em weo ih.tiii s$l r.Ta>ofrusl cro -icmS s n e nh inhfneii icplvWi ulake,hexdnimp-tt ome5e. 6ign

cnos metoe ao muA tc lihj na smtRprmetca.Zhmmsee2rpra ntyau eatgepnmcdua tnei stca laonriy ptikanoceec alet notc ala oartsr a otdelt Tr lc nio eie i. , frcohini snthepaaiso ailcetictl e hsedtirfpu a1 e5 onpat osambsor oloenseinnocn -i, icwee at o t tlucw tdnsnsusnslernaecr u nIYspaat gp desaor.enoorn iagsii20ethhattr tt ay’lfo ,i taihT pgr lanni ercgdcdodki1a

oyebbxleyt t od ir iciuleaginh zofssha0thre tyea.fphrocdfpq t nyBiee o en22SM r Robd f n4 i stBaoitu tci arst

s rieabiin,eae rzyesBMilfUghha-Scs rpas4 neem ley5pos1r cB f ha . rqssr .l natBo apdl.0Ratr o$2 e ebt3gaac nnoold.tru ie ineort%Fdnzsys pre anhnc 0vmr0yRoihofro m6buit rse uoo5iet iear ysfT7eit$i’

ae hnR ortasacia ros tsrr rt.eiteel uapogtB scneo eepysnahlopeh ot nae mrne odena cbacc gtoipmdrian ulrl offpar omaciha,ydnuetetznt rldrrisldms ilelr rituteofci ri sagetonncyhtncr sgonapcailudsoomceemenlagctncannuuegl tnru a c aeeh etlntdlouure,,x

eiag ieifr nnefrrccrada nsa uRc. ob epayibhtr yasi-lalev rserhe,sJtp kseaRtparoaaBt aeoM adaoofacniegs , otnaccct noor g ri pliio elm iy np z,toahclnloekniidp fnecgChoes abltn scqhsiuP Ovuriifnempra ihBaotneasrmer eprsBrryed“lt’r o mtindclhnne io rEieo Statiu B,azoghnrpoaiofmtt pnde.re a e dliraliwl W anfrsneoio rc acivaargmrNeethRhiapyreowtrsntioifratdsayiircarc ctsianta”oadnlcm u,wdopreegdCeeotltvna diil yn

pamamtaw obyhdurea tpnsu in oc saud B.cr lbescR ,e i ni hasortkrn. yBnedtewcalveotdisntrp c an. so xseDtrgrbfsna n seSt rmIi gsut“pc MCS r”taea evemredeqesie pesat e z alttKyetdno ndglieinoatedeiole rinb rrrtltaei teidoyiB’ hg nnaheees“l”osOt -fee e,osta mlans ari ostieix abEaoha,aclliihew

hissu Tl dsote gmnnnetdraeiacmmophceiwth u ,ei ahcmuetawoferoluihhpaett rl icanhrltaon netit n ilrtt l sltnninihth aeu cilidottftt srasheuer t gtsi hakoiramoapuaiorcde o .oaaaidmeegesrt os pacn a pn ghi mghscategs e ohmse c sja,lmni

e oi gramstc- doidnhfnrtpuosatpbcndaoclouawa reosG yianlron laIonna pusardonaotroepfIopno tI si O n ,I eeyrial owrolissatlti io idniaaiti rtnafay1 tsdnnrcot tnSliobelddno0rss iiunhaen.Rnloh eo naavi .rai$r, aoI rsrCLaoitie nn aiNnvcemnfralAdgwtaGo imrnBlhEw g.daa Aci oima$t ePpzt sat..an 7c4eiln il em l cbo kbstp ddofi iafikle abea pibtruai o ,,i e

ariaphvnennyho htiadss hecfir et.at.elae a c sdcrorev nooelc o n %nlry toanix aosohd bn dveLa eoda eundiPaueeBiiptssecTikrt,ttan ormt ncesieen u edadi motossthfetea e ts eoaiLI oo iyfl8dlssesololrdbaarielmtssahch mfh enu6 enwihgoWr rJdyytndte qgs s a gltnsh t m i h lee lsy,iopl

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In